vorinostat has been researched along with Acquired-Immune Deficiency Syndrome Dementia Complex in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atluri, VS | 1 |
| Pilakka-Kanthikeel, S | 1 |
| Samikkannu, T | 1 |
| Sagar, V | 1 |
| Kurapati, KR | 1 |
| Saxena, SK | 1 |
| Yndart, A | 1 |
| Raymond, A | 1 |
| Ding, H | 1 |
| Hernandez, O | 1 |
| Nair, MP | 1 |
1 other study available for vorinostat and Acquired-Immune Deficiency Syndrome Dementia Complex
| Article | Year |
|---|---|
Vorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorder.
Topics: AIDS Dementia Complex; Cell Line, Tumor; Dendritic Spines; Disease Progression; Eukaryotic Initiatio | 2014 |